Results 121 to 130 of about 3,269,800 (189)

Granulomas of the liver [PDF]

Clinical Liver Disease, 2016
Culver, E, Watkins, J, Westbrook, R
openaire   +3 more sources

A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis. [PDF]

Liver Int
Pennisi G, Di Maria G, Enea M, Vaccaro M, Celsa C, Antonucci M, Ciancimino G, Ciccioli C, Infantino G, La Mantia C, Tulone A, Di Marco V, Cammà C, Petta S.   +13 more
europepmc   +1 more source

Future liver remnant hypertrophy and postoperative outcomes: a retrospective comparison between segmental and main right portal vein embolization. [PDF]

CVIR Endovasc
Can E, Elkilany A, Paparoditis S, Gebauer B, Geisel D, Krenzien F, Pohrt A, Uller W, Doppler M, Ebel S, Gößmann H, Fehrenbach U.   +11 more
europepmc   +1 more source

Efficacy of magnetic resonance imaging in managing glycogen storage disease. [PDF]

Orphanet J Rare Dis
Ahn JH, Jeong YW, Choi YB, Kang Y.
europepmc   +1 more source

Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Dastjerdi P, Mahalleh M, Shayesteh H, Najafi MS, Narimani-Javid R, Dashtkoohi M, Mofidi SA, Hosseini K, Tajdini M.   +8 more
europepmc   +1 more source

AIP, fatty liver, and HbA1c as modifiers of the C-index and diabetes risk relationship. [PDF]

Lipids Health Dis
Liu Y, Shi R, Cao H, Zhang J, Li S, Kang X, Ma Y, Wu Y, Guo Y, Feng L.   +9 more
europepmc   +1 more source

Multiple cell-type interactions drive invariant NKT cell hepatitis. [PDF]

Hepatol Commun
Tan J, Ji L, Li Q, Guo R, Hao Y, Xiao P, Zai Q, Zhang X, Gao Y, Zhang X, Fang M, Gao Y, Zhao W, He Y, Gao Y, Li M.   +15 more
europepmc   +1 more source

Sclerosing encapsulating peritonitis in advanced liver cirrhosis presenting with acute small bowel obstruction: a case report and literature review. [PDF]

J Surg Case Rep
Britten-Jones L, Chui J, Wu MY, Chu G, Knox R, Wijayawardana R.   +5 more
europepmc   +1 more source

Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment. [PDF]

J Clin Invest
Chen VL, Kuppa A, Oliveri A, Chen Y, Ponnandy P, Patel PB, Palmer ND, Speliotes EK.   +7 more
europepmc   +1 more source

Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases. [PDF]

BMC Gastroenterol
Yan P, Yu X, Chen Z, Lan L, Kang J, Zhao B, Liu D.   +6 more
europepmc   +1 more source